Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AC
- Chemical substanceL04AC12Brodalumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
At a glance
- ATC code
- L04AC12
- Registers
- 8
- Registrations
- 8
- With their own page
- 8
- Companies
- 6
All medicines with Brodalumab
Human medicines from every register that match Brodalumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Siliq | United States | 210MG/1.5ML | injectable | Marketed | Valeant Luxembourg |
| Kyntheum | European Union | Authorised | LEO Pharma A/S | ||
| Kyntheum 210 MG Solucion Inyectable en Jeringa Precargada | Spain | 210 mg | solución inyectable | Marketed | Leo Pharma A/S |
| Kyntheum 210 mg, oplossing voor injectie in voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | AstraZeneca UK Limited | |
| Siliq | Canada | 210 MG / 1.5 ML | Solution | Marketed | Bausch Health, Canada INC. |
| LUMICEF Subcutaneous Injection 210mg Syringe | Taiwan | 注射液劑 | Authorised | 台灣大昌華嘉股份有限公司 | |
| Kyntheum | Brazil | Authorised | Leo Pharma Ltda | ||
| Kyntheum | Croatia | Authorised |